115 related articles for article (PubMed ID: 12496447)
1. Antagonist of secondary lymphoid-tissue chemokine (CCR ligand 21) prevents the development of chronic graft-versus-host disease in mice.
Sasaki M; Hasegawa H; Kohno M; Inoue A; Ito MR; Fujita S
J Immunol; 2003 Jan; 170(1):588-96. PubMed ID: 12496447
[TBL] [Abstract][Full Text] [Related]
2. IL-18 prevents the development of chronic graft-versus-host disease in mice.
Okamoto I; Kohno K; Tanimoto T; Iwaki K; Ishihara T; Akamatsu S; Ikegami H; Kurimoto M
J Immunol; 2000 Jun; 164(11):6067-74. PubMed ID: 10820292
[TBL] [Abstract][Full Text] [Related]
3. The chemokine SLC is expressed in T cell areas of lymph nodes and mucosal lymphoid tissues and attracts activated T cells via CCR7.
Willimann K; Legler DF; Loetscher M; Roos RS; Delgado MB; Clark-Lewis I; Baggiolini M; Moser B
Eur J Immunol; 1998 Jun; 28(6):2025-34. PubMed ID: 9645384
[TBL] [Abstract][Full Text] [Related]
4. Blockade of secondary lymphoid tissue chemokine exacerbates Propionibacterium acnes-induced acute lung inflammation.
Itakura M; Tokuda A; Kimura H; Nagai S; Yoneyama H; Onai N; Ishikawa S; Kuriyama T; Matsushima K
J Immunol; 2001 Feb; 166(3):2071-9. PubMed ID: 11160258
[TBL] [Abstract][Full Text] [Related]
5. Chondroitin sulfate B exerts its inhibitory effect on secondary lymphoid tissue chemokine (SLC) by binding to the C-terminus of SLC.
Hirose J; Kawashima H; Swope Willis M; Springer TA; Hasegawa H; Yoshie O; Miyasaka M
Biochim Biophys Acta; 2002 Jul; 1571(3):219-24. PubMed ID: 12090936
[TBL] [Abstract][Full Text] [Related]
6. A high migratory capacity of donor T-cells in response to the lymph node homing receptor CCR7 increases the incidence and severity of GvHD.
Portero-Sainz I; Gómez-García de Soria V; Cuesta-Mateos C; Fernández-Arandojo C; Vega-Piris L; Royg M; Colom-Fernández B; Marcos-Jiménez A; Somovilla-Crespo B; Ramírez-Mengíbar A; López-Huete V; de Rosendo-Serrano A; Kreutzman A; Muñoz-Calleja C
Bone Marrow Transplant; 2017 May; 52(5):745-752. PubMed ID: 28112745
[TBL] [Abstract][Full Text] [Related]
7. Local delivery of recombinant vaccinia virus expressing secondary lymphoid chemokine (SLC) results in a CD4 T-cell dependent antitumor response.
Flanagan K; Glover RT; Hörig H; Yang W; Kaufman HL
Vaccine; 2004 Jul; 22(21-22):2894-903. PubMed ID: 15246626
[TBL] [Abstract][Full Text] [Related]
8. Secondary lymphoid-tissue chemokine is a functional ligand for the CC chemokine receptor CCR7.
Yoshida R; Nagira M; Kitaura M; Imagawa N; Imai T; Yoshie O
J Biol Chem; 1998 Mar; 273(12):7118-22. PubMed ID: 9507024
[TBL] [Abstract][Full Text] [Related]
9. Preferential blockade of CD8(+) T cell responses by administration of anti-CD137 ligand monoclonal antibody results in differential effect on development of murine acute and chronic graft-versus-host diseases.
Nozawa K; Ohata J; Sakurai J; Hashimoto H; Miyajima H; Yagita H; Okumura K; Azuma M
J Immunol; 2001 Nov; 167(9):4981-6. PubMed ID: 11673505
[TBL] [Abstract][Full Text] [Related]
10. Secondary lymphoid tissue chemokine mediates T cell-dependent antitumor responses in vivo.
Sharma S; Stolina M; Luo J; Strieter RM; Burdick M; Zhu LX; Batra RK; Dubinett SM
J Immunol; 2000 May; 164(9):4558-63. PubMed ID: 10779757
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effects of the mouse chemokine 6Ckine/SLC through angiostatic and immunological mechanisms.
Vicari AP; Ait-Yahia S; Chemin K; Mueller A; Zlotnik A; Caux C
J Immunol; 2000 Aug; 165(4):1992-2000. PubMed ID: 10925282
[TBL] [Abstract][Full Text] [Related]
12. T cell-dependent antitumor immunity mediated by secondary lymphoid tissue chemokine: augmentation of dendritic cell-based immunotherapy.
Kirk CJ; Hartigan-O'Connor D; Nickoloff BJ; Chamberlain JS; Giedlin M; Aukerman L; Mule JJ
Cancer Res; 2001 Mar; 61(5):2062-70. PubMed ID: 11280767
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic analysis of donor cells infiltrating the small intestinal epithelium and spleen during graft-versus-host disease.
Schattenfroh NC; Hoffman RA; McCarthy SA; Simmons RL
Transplantation; 1995 Jan; 59(2):268-73. PubMed ID: 7839451
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of Th1 and Th2 cytokine production during the early course of acute and chronic murine graft-versus-host disease. Regulatory role of donor CD8+ T cells.
Rus V; Svetic A; Nguyen P; Gause WC; Via CS
J Immunol; 1995 Sep; 155(5):2396-406. PubMed ID: 7650373
[TBL] [Abstract][Full Text] [Related]
15. CC chemokine receptor 2 expression in donor cells serves an essential role in graft-versus-host-disease.
Rao AR; Quinones MP; Garavito E; Kalkonde Y; Jimenez F; Gibbons C; Perez J; Melby P; Kuziel W; Reddick RL; Ahuja SK; Ahuja SS
J Immunol; 2003 Nov; 171(9):4875-85. PubMed ID: 14568968
[TBL] [Abstract][Full Text] [Related]
16. A lymphocyte-specific CC chemokine, secondary lymphoid tissue chemokine (SLC), is a highly efficient chemoattractant for B cells and activated T cells.
Nagira M; Imai T; Yoshida R; Takagi S; Iwasaki M; Baba M; Tabira Y; Akagi J; Nomiyama H; Yoshie O
Eur J Immunol; 1998 May; 28(5):1516-23. PubMed ID: 9603456
[TBL] [Abstract][Full Text] [Related]
17. Differential effect of CTLA4Ig on murine graft-versus-host disease (GVHD) development: CTLA4Ig prevents both acute and chronic GVHD development but reverses only chronic GVHD.
Via CS; Rus V; Nguyen P; Linsley P; Gause WC
J Immunol; 1996 Nov; 157(9):4258-67. PubMed ID: 8892665
[TBL] [Abstract][Full Text] [Related]
18. SLC/exodus2/6Ckine/TCA4 induces chemotaxis of hematopoietic progenitor cells: differential activity of ligands of CCR7, CXCR3, or CXCR4 in chemotaxis vs. suppression of progenitor proliferation.
Kim CH; Broxmeyer HE
J Leukoc Biol; 1999 Sep; 66(3):455-61. PubMed ID: 10496316
[TBL] [Abstract][Full Text] [Related]
19. The role of endogenous glucocorticoids on host T cell populations in the peripheral lymphoid organs of mice with graft-versus-host disease.
You-Ten KE; Lapp WS
Transplantation; 1996 Jan; 61(1):76-83. PubMed ID: 8560578
[TBL] [Abstract][Full Text] [Related]
20. CTL-Promoting Effects of IL-21 Counteract Murine Lupus in the Parent→F1 Graft-versus-Host Disease Model.
Nguyen V; Rus H; Chen C; Rus V
J Immunol; 2016 Feb; 196(4):1529-40. PubMed ID: 26792801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
